Soleno Therapeutics (SLNO) Revenue (2013 - 2026)
Soleno Therapeutics (SLNO) revenue from Sep 30, 2013 to Mar 31, 2026. The TTM Soleno Therapeutics (SLNO) revenue is $285M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Soleno Therapeutics (SLNO) Revenue CAGR table
| Period | CAGR |
|---|---|
| 10 Years TTM | +75.30% |
Annual Revenue change of Soleno Therapeutics (SLNO)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $95M | -50.32% |
| 2025 | $190M | N/A |
| 2024 | $0 | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | -100.00% |
| 2016 | $1.45M | +137.70% |
| 2015 | $610K | N/A |
| 2014 | $0 | -100.00% |
| 2013 | $3M | N/A |